Healio

Blood-based tau pathology test for Alzheimer’s disease in development

A clinical diagnostics company and biotech firm have announced a partnership to develop a blood-based tau pathology test that would assist in the diagnosis of Alzheimer’s disease. In a press release, ...
Kaleido Scope

Leal appointed to the American Board of Pathology Test Development and Advisory Committee for Medical Microbiology

Sixto M. Leal Jr., M.D., Ph.D., Jay M. McDonald Endowed Professor in Experimental Pathology and Division Director, Laboratory Medicine, has been appointed to the American Board of Pathology's (ABPath) ...
Healio

Blood tests for AD pathology may improve diagnostic accuracy, treatment in primary care

Please provide your email address to receive an email when new articles are posted on . Adults with cognitive complaints received usual care by primary care physicians and were tested for blood-based ...
Business Wire

Owkin unveils new insights into the opportunities and challenges for digital pathology and AI solutions in healthcare

PARIS--(BUSINESS WIRE)--Owkin, the first end-to-end AI-biotech that uses cutting-edge AI to unlock precision drug discovery, development, and diagnostics, has launched its latest report, State of the ...
Business Wire

Veravas Partners with Phanes Biotech to Co-develop a Next-generation Blood-based Tau Pathology Test to Improve Alzheimer's Disease Detection

First-in-class blood-based assay is designed to precisely detect tau pathology and to characterize Alzheimer’s disease progression in symptomatic and presymptomatic patients AUSTIN, Texas & MALVERN, ...

FDA clears blood test to help rule out Alzheimer’s disease in people showing symptoms

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...